4-oxo-N-[[4-(propylaminomethyl)phenyl]methyl]-3H-thieno[2,3-d]pyrimidine-5-carboxamide
C18H20N4O2S — CID 73334470
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-oxo-N-[[4-(propylaminomethyl)phenyl]methyl]-3H-thieno[2,3-d]pyrimidine-5-carboxamide
4-oxo-N-[[4-(propylaminomethyl)phenyl]methyl]-3H-thieno[2,3-d]pyrimidine-5-carboxamide (PubChem CID 73334470) has the molecular formula C18H20N4O2S and a molecular weight of 356.45 g/mol. Its IUPAC name is 4-oxo-N-[[4-(propylaminomethyl)phenyl]methyl]-3H-thieno[2,3-d]pyrimidine-5-carboxamide.
Molecular Properties
| Compound Name | 4-oxo-N-[[4-(propylaminomethyl)phenyl]methyl]-3H-thieno[2,3-d]pyrimidine-5-carboxamide |
|---|---|
| PubChem CID | 73334470 |
| Molecular Formula | C18H20N4O2S |
| Molecular Weight | 356.45 g/mol |
| Exact Mass | 356.13 |
| IUPAC Name | 4-oxo-N-[[4-(propylaminomethyl)phenyl]methyl]-3H-thieno[2,3-d]pyrimidine-5-carboxamide |
| SMILES | CCCNCc1ccc(CNC(=O)c2csc3nc[nH]c(=O)c23)cc1 |
| InChI | InChI=1S/C18H20N4O2S/c1-2-7-19-8-12-3-5-13(6-4-12)9-20-16(23)14-10-25-18-15(14)17(24)21-11-22-18/h3-6,10-11,19H,2,7-9H2,1H3,(H,20,23)(H,21,22,24) |
| InChIKey | PJVMLLVDDLGFHU-UHFFFAOYSA-N |
| XLogP | 2.41 |
| TPSA | 86.88 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 356.45 |
| LogP ≤ 5 | 2.41 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 73334470 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.